17th Annual UCLA Liver Diseases Symposium

Important Update (06/05/24): Symposium Date Change
Please note that the course originally scheduled for October 12, 2024, has been rescheduled to October 26, 2024. 

The 17th Annual UCLA Liver Diseases Symposium will provide a state-of-the-art update and scientific exchange on prevalent liver diseases and their complications using a multi-disciplinary approach with hepatologists, radiologists and surgeons.

In-Person & Virtual Fees 

• $50 Physicians
• $35 Nurses and Other Allied Healthcare Professionals
• $25 Fellows and Residents

Recharge Payment Information
Registration payment can be submitted via the Interdepartmental recharge system.
For more details, please refer to document here: Recharge Information

Refunds
Due to the low enrollment fee, no refunds will be offered. A full refund will be provided if this course is cancelled, or postponed.

Course Recording
All registrants (live or virtual) will be provided the opportunity to review recorded sessions up to 3 weeks following the conference.
The recorded sessions are not approved for Continuing Education (CE) credit. 

1. Diagnose and manage patients with advanced liver disease and be better able to prognosticate and risk stratify those patients for medical procedures.
2. Understand the current process of evaluation, listing and organ allocation in liver transplantation.
3. Identify the risks and benefits of interventional radiology (IR) procedures for the management and treatment of clinically significant portal hypertension in patients with advanced liver disease.
4. Use evidence-based recommendations in the evaluation and management of hepatocellular carcinoma (HCC).
5. Discuss the role of current and recently approved second line therapies in the treatment of primary biliary cholangitis (PBC).
6. Evaluate and properly stratify patients with metabolic dysfunctionassociated steatotic liver disease (ie, fatty liver), and develop tailored therapies to prevent disease progression.
7. Review treatment options for patients with alcohol hepatitis and optimal long-term care.
8. Identify the most common causes of drug induced liver injury (DILI) and learn to assess which cases are likely to resolve or progress.
9. Diagnose acute liver failure, risk stratify patients, and identify those likely to recover and those likely to require a liver transplant.

The California State Board of Registered Nursing
accepts courses approved for the AMA PRA Category 1 Credits^TM as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies.

The American Board for Transplant Certification (ABTC)
The American Board for Transplant Certification (ABTC) has approved this educational offering for up to 4.25 Category One Continuing Education Points for Transplant Certification (CEPTCs).

Conference Location

Barcelona/Cataluna Ballroom
Hyatt Regency Westlake
880 S Westlake Blvd, Westlake Village, CA 91361
(805) 557-1234

Parking

Self Parking – Complimentary
Valet Parking – $15 per vehicle

Mitigation of Relevant Financial Relationships

The Accreditation Council for Continuing Medical Education (ACCME), Standards for Integrity and Independence mandates that the accreditation manages all identified relevant financial relationship(s) before the program and adequately discloses relationships to learners. The David Geffen School of Medicine at UCLA adheres to the ACCME Standards for Integrity and Independence in accredited continuing education.

The individuals below have been identified as having a position to influence the content of this educational activity. As such, they have disclosed the absence or presence of a relevant financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All of the relevant financial relationships for these individuals have been mitigated.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Daniel Chambers
UCLA

CCPD Staff

Nothing to disclose

Ericka Cunningham, MBA
UCLA David Geffen School of Medicine

CCPD Staff

Nothing to disclose

Charles Flippen II, MD, FAAN, FANA
David Geffen School of Medicine at UCLA

CCPD Staff

Nothing to disclose

Kimberly Valencia, CHCP
UCLA David Geffen School of Medicine

CCPD Staff

Nothing to disclose

Fady M Kaldas, MD
UCLA Department of Surgery

Co-Director, Faculty

Nothing to disclose

Sammy Saab, MD, AGAF, MPH
UCLA

Course Director, Faculty

Speakers Bureau-AbbVie (Any division)|Speakers Bureau-madrigal|Honoraria-Ipsen Biopharmaceuticals, Inc.|Speakers Bureau-Gilead Sciences, Inc. Gilead Sciences, Inc. Gilead Sciences, Inc.|Speakers Bureau-Bausch (formerly Salix)|Speakers Bureau-Mallinckrodt Pharmaceuticals|Speakers Bureau-Eisai, Inc.|Speakers Bureau-Exelixis, Inc. (Relationship has ended)|Speakers Bureau-Takeda Pharmaceuticals (Relationship has ended)

Vatche Agopian, MD, Professor of Surgery
UCLA David Geffen School of Medicine

Faculty

Consulting Fee-Merck (Any division) Merck (Any division)|Consulting Fee-Eximius Inc

Gina Choi, MD, Associate Professor of Medicine and Surgery
UCLA David Geffen School of Medicine

Faculty

Speakers Bureau-Intercept Pharmaceuticals, Inc.|Speakers Bureau-Ipsen Biopharmaceuticals, Inc.|Speakers Bureau-Madrigal|Speakers Bureau-Gilead Sciences, Inc. Gilead Sciences, Inc. Gilead Sciences, Inc.

Tien Dong, MD, PhD
UCLA

Faculty

Speakers Bureau-Mallinckrodt Pharmaceuticals|Membership on Advisory Committees or Review Panels, Board Membership, etc.-PurposeBio

Samer Ebaid, MD, PhD, MS, Assistant Professor of Surgery
UCLA David Geffen School of Medicine

Faculty

Nothing to disclose

Douglas Farmer, MD, PHYSICIAN
UCLA HEALTH

Faculty

Nothing to disclose

Steven-Huy B Han, MD, AGAF, FAASLD, Professor of Medicine & Surgery
UCLA David Geffen School of Medicine

Faculty

Speakers Bureau-Gilead Sciences, Inc. Gilead Sciences, Inc. Gilead Sciences, Inc.

James Zhe Hui, MD, PhD
UCLA

Faculty

Nothing to disclose

Sentia Iriana, MD
UCLA Health

Faculty

Nothing to disclose

Julio Meza, MD
UCLA

Faculty

Nothing to disclose

June Ramsay, BS, HCSA
UCLA

Faculty

Nothing to disclose

Saeed Sadeghi, MD, Professor of Medicine
UCLA Medical Center

Faculty

Nothing to disclose

Akshay Shetty, MD, Assistant Professor of Medicine and Surgery
UCLA David Geffen School of Medicine

Faculty

Nothing to disclose

Jasleen Singh, MD, Assistant Professor of Medicine and Surgery
UCLA David Geffen School of Medicine

Faculty

Nothing to disclose

Ann Toggenburger, NA
UCLA

Faculty

Beshoy Yanny, MD
UCLA

Faculty

Nothing to disclose

Saturday, October 26, 2024

Acknowledgments
This program is supported in part by educational grants and exhibitors from the following:

Educational Grant

• Salix Pharmaceuticals
• Orphalan INC.
• Gilead Sciences, INC.
• ORPHALAN INCORPHALAN INC

Exhibitors

• Abbvie
• Acariahealth
• AstraZeneca
• Echosens
• Exelixis
• Fujifilm
• Gilead
• Innoviva
• Ipsen
• Madrigal
• Mallnckrodt
• Mirum
• Orphalan
• Salix